170 related articles for article (PubMed ID: 31136248)
1. Barriers to Ensuring Access to Affordable Prescription Drugs.
Mello MM
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():275-289. PubMed ID: 31136248
[TBL] [Abstract][Full Text] [Related]
2. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
3. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
Wineinger NE; Zhang Y; Topol EJ
JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
[TBL] [Abstract][Full Text] [Related]
4. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
[TBL] [Abstract][Full Text] [Related]
5. Americans' access to prescription drugs stabilizes, 2007-2010.
Boukus ER; Carrier ER
Track Rep; 2011 Dec; (27):1-5. PubMed ID: 22180943
[TBL] [Abstract][Full Text] [Related]
6. Reducing Branded Prescription Drug Prices: A Review of Policy Options.
Alexander GC; Ballreich J; Socal MP; Karmarkar T; Trujillo A; Greene J; Sharfstein J; Anderson G
Pharmacotherapy; 2017 Nov; 37(11):1469-1478. PubMed ID: 28805961
[TBL] [Abstract][Full Text] [Related]
7. Fair global drug pricing.
Campbell JD; Kaló Z
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):581-583. PubMed ID: 30215535
[No Abstract] [Full Text] [Related]
8. Rising Cost of Anticancer Medications in the United States.
Jackson K; Nahata MC
Ann Pharmacother; 2017 Aug; 51(8):706-710. PubMed ID: 28707550
[TBL] [Abstract][Full Text] [Related]
9. Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell Lung Cancer in the US From 2015 to 2020.
Desai A; Scheckel C; Jensen CJ; Orme J; Williams C; Shah N; Leventakos K; Adjei AA
JAMA Netw Open; 2022 Jan; 5(1):e2144923. PubMed ID: 35076701
[TBL] [Abstract][Full Text] [Related]
10. Generic Drugs in the United States: Policies to Address Pricing and Competition.
Gupta R; Shah ND; Ross JS
Clin Pharmacol Ther; 2019 Feb; 105(2):329-337. PubMed ID: 30471089
[TBL] [Abstract][Full Text] [Related]
11. Getting to the Root of High Prescription Drug Prices.
Waxman H; Corr B; Martin K; Duong S
Issue Brief (Commonw Fund); 2017 Jul; 2017():1-10. PubMed ID: 28700190
[TBL] [Abstract][Full Text] [Related]
12. Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?
Sarpatwari A; Avorn J; Kesselheim AS
BMJ; 2020 Oct; 371():m3841. PubMed ID: 33032982
[No Abstract] [Full Text] [Related]
13. Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards.
Bendicksen L; Rome BN; Avorn J; Kesselheim AS
Milbank Q; 2021 Dec; 99(4):1162-1197. PubMed ID: 34375015
[TBL] [Abstract][Full Text] [Related]
14. States as Activists.
Buck ID
J Leg Med; 2019; 39(2):121-136. PubMed ID: 31503528
[TBL] [Abstract][Full Text] [Related]
15. Prescription drug prices in the US.
Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
[No Abstract] [Full Text] [Related]
16. Enhancing medicine price transparency through price information mechanisms.
Hinsch M; Kaddar M; Schmitt S
Global Health; 2014 May; 10():34. PubMed ID: 24885767
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis.
Moodley R; Suleman F
BMC Health Serv Res; 2019 Aug; 19(1):576. PubMed ID: 31419977
[TBL] [Abstract][Full Text] [Related]
18. Information system technologies' role in augmenting dermatologists' knowledge of prescription medication costs.
DeMarco SS; Paul R; Kilpatrick RJ
Int J Med Inform; 2015 Dec; 84(12):1076-84. PubMed ID: 26228652
[TBL] [Abstract][Full Text] [Related]
19. Prescription Drug Price Paradox: Cost Analysis of Canadian Online Pharmacies versus US Medicare Beneficiaries for the Top 100 Drugs.
Kim SH; Ryu YJ; Cho NE; Kim AE; Chang J
Clin Drug Investig; 2017 Oct; 37(10):957-963. PubMed ID: 28735450
[TBL] [Abstract][Full Text] [Related]
20. Determinants of branded prescription medicine prices in OECD countries.
Kanavos PG; Vandoros S
Health Econ Policy Law; 2011 Jul; 6(3):337-67. PubMed ID: 21676345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
